Lawande Sachin 4

4 · VISTEON CORP · Filed Mar 5, 2026

Form 4

Period: 2026-03-04

DirectorCEO and President

Transactions

Exercise/Conversion
Common Stock
[F1][F2]
2026-03-04$80.97/sh+49,453$4,004,209→ 224,980 total
Sale
Common Stock
[F3]
2026-03-04$92.90/sh−25,299$2,350,277→ 199,681 total
Sale
Common Stock
[F4]
2026-03-04$93.76/sh−17,911$1,679,335→ 181,770 total
Sale
Common Stock
[F5]
2026-03-04$94.69/sh−6,243$591,150→ 175,527 total
Exercise/Conversion
Employee Stock Option (right to buy)
[F1][F6]
2026-03-04−49,453→ 0 total
Exercise: $80.97Exp: 2026-03-06→ Common Stock (49,453 underlying)

Holdings

Footnotes (6)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025.
[F2]The options will expire if not exercised prior to March 6, 2026.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.37 - $93.36, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.37 - $94.36, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 - $95.13, inclusive.
[F6]The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.

Signature

Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Sachin S. Lawande|2026-03-05

Documents

1 file